TOOS CAS:82692-93-1 Mutengo wemugadziri
Solubilization uye kudzikamisa: MB-β-CD inowanzoshandiswa kusimbisa kunyungudika uye kugadzikana kwemishonga isina kunaka inonyungudika mumvura.Inogona kuumba inclusion complexes ine hydrophobic drug molecules, ichiwedzera kunyungudika kwavo uye bioavailability.
Kuendesa zvinodhaka: MB-β-CD inoshandiswa semutakuri wehurongwa hwekuunza zvinodhaka.Iyo inogona kuvharira mishonga mukati meiyo hydrophobic cavity, ichivadzivirira kubva mukuora uye kuvaendesa kune yakatarwa nzvimbo.
Kuravira masking: MB-β-CD inogona kuvhara kuravira kusingafadzi kana kunhuwa kwemamwe mishonga, kuvandudza kugamuchirwa kwemurwere uye kutevedzera.
Chiral separation: Inoshandiswa mu analytical chemistry yeanoselective separation ye chiral compounds.MB-β-CD inoumba inclusion complexes ine chiral molecules, ichibvumira kupatsanurwa kwavo zvichienderana nehukama hwavo hwakasiyana kune CD cavity.
Zvekuzora nekuchengeta pachezvako: MB-β-CD inoshandiswa mukugadzira zvizorwa uye zvekuchengeta zvemunhu zvakadai semafuta ekuzora, makirimu, uye mashamposi.Inogona kuvandudza kunyungudika uye kugadzikana kwezvinhu zvinoshanda, kusimudzira kuendesa kwavo kuganda, uye kubatsira mukuumbwa kwechigadzirwa uye kugadzikana.
Composition | C12H20NNaO4S |
Assay | 99% |
Chitarisiko | Chenaupfu |
CAS Nha. | 82692-93-1 |
Packing | Zvidiki uye zvakawanda |
Sherufu Hupenyu | 2 years |
Storage | Chengetedza munzvimbo inotonhorera uye yakaoma |
Certification | ISO. |